Is statin-induced diabetes clinically relevant? A comprehensive review of the literature

Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus

(2013) Eliano Pio Navarese et al.   AMERICAN JOURNAL OF CARDIOLOGY

Postprandial Dysmetabolism: The Missing Link Between Diabetes and Cardiovascular Events?

(2013) David Bell et al.   Endocrine Practice

Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure

(2013) Yu-Heng Chung et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia

(2013) Tomoya Mita et al.   Journal of Diabetes Investigation

Statin Intake Is Associated With Decreased Insulin Sensitivity During Cardiac Surgery

(2012) H. Sato et al.   DIABETES CARE

Colesevelam Improves Oral but Not Intravenous Glucose Tolerance by a Mechanism Independent of Insulin Sensitivity and  -Cell Function

(2012) A. L. Marina et al.   DIABETES CARE

Adiponectin: mechanistic insights and clinical implications

(2012) A. T. Turer et al.   DIABETOLOGIA

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

(2012) Paul M Ridker et al.   LANCET

Randomized Head-to-Head Comparison of Pitavastatin, Atorvastatin, and Rosuvastatin for Safety and Efficacy (Quantity and Quality of LDL)

(2011) Keijiro Saku et al.   CIRCULATION JOURNAL

Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes-the CORALL study

(2011) S. Simsek et al.   DIABETIC MEDICINE

Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance

(2011) E. Moutzouri et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

(2011) David Preiss   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Influence of Pitavastatin on Glucose Tolerance in Patients with Type 2 Diabetes Mellitus

(2011) Tadashi Yamakawa et al.   Journal of Atherosclerosis and Thrombosis

ATORVASTATIN BUT NOT PITAVASTATIN SIGNIFICANTLY INCREASES FASTING PLASMA GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES AND COMBINED DYSLIPIDEMIA

(2011) Vladimir Kryzhanovski et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin

(2011) David D. Waters et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of pravastatin and rosuvastatin on the generation of adiponectin in the visceral adipose tissue in patients with coronary artery disease

(2010) Hiroaki Yokoyama et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Atorvastatin Causes Insulin Resistance and Increases Ambient Glycemia in Hypercholesterolemic Patients

(2010) Kwang Kon Koh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin

(2010) William L Holland et al.   NATURE MEDICINE

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

(2009) S. N. Rajpathak et al.   DIABETES CARE

Rediscovering bile acid sequestrants

(2009) D. S. H. Bell et al.   DIABETES OBESITY & METABOLISM

The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients

(2009) Shosaku Nomura et al.   PLATELETS

Prevalence and predictors of lipid abnormalities in patients treated with statins in the UK general practice

(2008) H. Phatak et al.   ATHEROSCLEROSIS

Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients

(2008) Kwang Kon Koh et al.   ATHEROSCLEROSIS

Comparison of the Effect of Lipophilic and Hydrophilic Statins on Serum Adiponectin Levels in Patients with Mild Hypertension and Dyslipidemia: Kinki Adiponectin Interventional (KAI) Study

(2008) Tatsuya Kai et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Atorvastatin Administration after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease and Normal Lipid Profiles: Impact on Plasma Adiponectin Level

(2008) Kuei-Chuan Chan et al.   CLINICAL CARDIOLOGY

The Effect of Atorvastatin in Patients with Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Study

(2008) Thozhukat Sathyapalan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies

(2008) Naveed Sattar et al.   LANCET

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

(2008) GISSI-HF investigators   LANCET

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitus

(2007) Shosaku Nomura et al.   THROMBOSIS RESEARCH